The company is racing to advance its medical device for prostate cancer to a pivotal clinical study later this year. A Durham company wants to raise $10 million to advance its medical device to a ...
Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced ...
MINNEAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...
TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Maple Grove-based company ...
An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...
The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug ...
“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback